Daniel V Labarbera

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. pmc The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis
    Muthenna Puppala
    Department of Biochemistry, National Institute of Nutrition, Hyderabad, India
    PLoS ONE 7:e31399. 2012
  2. doi request reprint The multicellular tumor spheroid model for high-throughput cancer drug discovery
    Daniel V Labarbera
    The University of Colorado Denver, The Skaggs School of Pharmacy and Pharmaceutical Sciences the University of Colorado AMC, The Department of Pharmaceutical Sciences, 12850 East Montview Blvd Aurora Colorado C238, USA
    Expert Opin Drug Discov 7:819-30. 2012

Collaborators

  • Muthenna Puppala
  • Jessica Ponder
  • Palla Suryanarayana
  • Geereddy Bhanuprakash Reddy
  • J Mark Petrash

Detail Information

Publications3

  1. pmc The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis
    Muthenna Puppala
    Department of Biochemistry, National Institute of Nutrition, Hyderabad, India
    PLoS ONE 7:e31399. 2012
    ..This study supports the continued development of natural products such as β-glucogallin as therapeutic leads in the development of novel therapies to treat diabetic complications such as cataract...
  2. doi request reprint The multicellular tumor spheroid model for high-throughput cancer drug discovery
    Daniel V Labarbera
    The University of Colorado Denver, The Skaggs School of Pharmacy and Pharmaceutical Sciences the University of Colorado AMC, The Department of Pharmaceutical Sciences, 12850 East Montview Blvd Aurora Colorado C238, USA
    Expert Opin Drug Discov 7:819-30. 2012
    ..Technological advances in 3D-cell culture models bridge the gap between 2D and in vivo models to improve upon the current success rates of cancer drug discovery...